Global Blood Transfusion Diagnostics Market Is Poised To Expand Positively At A CAGR Of 6.3% During The Forecast Period (2022-2025)

The detailed research report on the Blood Transfusion Diagnostics Market focuses on the macro as well as microeconomic factors that are helping its development. The report also concentrates on the regulatory framework that is shaping the future of the global market. Furthermore, the research report also makes note of the existing as well as prevailing pricing structure, emerging areas of applications, and imminent investment opportunities in the global market.

The research report on the Blood Transfusion Diagnostics Market also provides an in-detailed analysis of the overall vendor landscape. The report analyzes the key marketing and promotional strategies adopted by the leading companies in the global market.

Request Sample

Furthermore, it takes into consideration the existing development, past events, and recent trends to provide a strong and unbiased opinion on the future direction in which these leading companies will be heading into.

To back its opinion, the research report covers all the factors and events such as mergers, acquisitions, takeovers, joint ventures, and strategic alliances. It also analyzes the entry barriers and overall intensity of the competition in the Blood Transfusion Diagnostics Market.

Technological Insights: Plasma Fractionation Key Technological Development of Market Players

The global blood transfusion diagnostics market is semi-consolidated, consisting of the following prominent market players: Grifols S.A., Bio-Rad Laboratories, Inc., Immucor, Inc., CSL Ltd., Abbott Laboratories, and DiaSorin S.p.A. These market players concentrate on introducing technological advancements in testing procedures. An example of such technological development is plasma fractionation.

Ask an Analyst:

Blood Transfusion Diagnostics: Market Segmentation

Fact.MR has studied the blood transfusion diagnostics market with detailed segmentation on the basis of product type, application, end-user and geography.

  • By Product Type :
    • Instruments
    • Kits & Reagents
  • By Application :
    • Blood Grouping
    • Disease Screening
    • Molecular Disease Screening
    • Serological Disease Screening
  • By End-user :
    • Hospitals
    • Diagnostic Laboratories
    • Blood Banks
    • Plasma Fractionation Companies
    • Others
  • By Geography :
    • North America
    • Europe
    • Asia Pacific
    • Eastern Europe
    • Latin America
    • Middle East & Africa (MEA)

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

Buy Now:
Regional Insights: North America Retains Hegemony, Asia-Pacific Presents Bankable Opportunities

North America is poised to remain the leader in the global blood transfusion diagnostics market. High percentage of voluntary blood donors and implementation of blood transfusion policies for safety and testing for infectious diseases are important growth drivers. The North American market is anticipated to expand at a positive CAGR of 6.4%, capturing over three-tenths of the overall market.

Asia-Pacific is anticipated to grow the fastest, registering a staggering CAGR of 7.0%, capturing greater than two-fifths of the global blood transfusion diagnostics market. This is attributed to high prevalence of TTIs in low-income countries, resulting in greater demand for disease-screening procedures. Moreover, there is a steady increase in the number of blood donation centers and blood donors. There is also an augmented demand for pre-transfusion testing.

Reasons to choose a Fact.MR:

  • Exhaustive research regarding the market to offer A to Z information.
  • Digital technologies to provide innovative business solutions to clients.
  • 24/7 availability of services.
  • Interaction with suppliers, vendors, and service providers for a precise market landscape.
  • Reports tailored as per the requirements of the clients.

Read More Trending Reports of Fact.MR :

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates